The issuer is solely responsible for the content of this announcement. Berlin, Germany, April 25, 2025 – Pentixapharm, a clinical-stage biopharmaceutical company focused on radiopharmaceuticals, will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback